Status:
UNKNOWN
Hyperbaric Therapy and Deep Chemical Peeling
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Chemical Peeling
Eligibility:
FEMALE
18-80 years
Phase:
PHASE1
Brief Summary
To evaluate whether treatment with Hyperbaric oxygen can accelerate skin recovery after deep peeling, and decrease frequency and severity of local side effects and complications. 20 post peel patient...
Detailed Description
The study will include 40 post-deep peel women (exoderm), older than 18 years old, treated by the same dermatologist. The treatment group will recieve 5 consecutive daily hyperbaric treatments, 1 hou...
Eligibility Criteria
Inclusion
- The study will include 40 post-deep peel women (exoderm), older than 18 years old, treated by the same dermatologist (dr. Landau).
- The treatment group will receive 5 consecutive daily hyperbaric treatments, 1 hours long each, at 2 ATF, starting from day 7 to peel. Prior to treatment, each patient will be signed on informed consent and will have complete physical examination.
- The control group will be matched by the following parameters: age, skin color and type, and indication for peeling, and will be picked up by the dermatologist.
Exclusion
- Patients will be excluded if they have known middle ear disease, chronic lung disease or claustrophobia
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00425789
Start Date
January 1 2007
End Date
July 1 2007
Last Update
April 5 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research & Development Unit, Assaf-Harofeh Medical Center
Ẕerifin, Israel, 70300